Our highly talented team of scientists have successfully launched and marketed NDAs, 505(b)(2)s and complex generic products across a wide range of dosage forms and technology platforms. Our trained professionals have the know-how to go from selection of a lead candidate to commercially launching a product, which includes a complete product development life-cycle – a must-have in this highly competitive marketplace.

​

Our scientific staff is keenly aware of protecting our intellectual property by means of patent protection, and, in some cases, challenging existing patents to bring patients desperately needed new products to the marketplace. Our co-development model looks to partner with companies who have synergies with us, and that specifically have disruptive technologies and breakthrough innovations.

​

Benefits for our co-development partners are that they get our highly talented and experienced team who have great track records leveraging our partner’s technologies with a speed of execution that enables us improve the health care of millions of patients. That, after all, is Nivagen’s primary objective: to improve the healthcare of millions of patients and create a better world for all.